Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2008
11/13/2008US20080279856 Using heparin-binding protein specific monoclonal antibody to decrease nonapeptide separation; prevention and treatment of inflammation
11/13/2008US20080279855 Dna Replication Modulating Peptides, Nucleic Acids Encoding Them, and Their Use in Pharmaceutical Compositions
11/13/2008US20080279854 Tumor suppressor antigen (5T4) for use as therapeutic tool in treatment and prevention of cell proliferative disorders
11/13/2008US20080279853 TNF-like weak inducer of apoptosis (TWEAK) specific immunoglobulin for use as therapeutic in treatment of pancreatic cell proliferative disorders
11/13/2008US20080279852 Methods of treatment with glycosylated antibodies
11/13/2008US20080279851 Type I transmembrane protein specific immunoglobulin for treatment and prevention of cell proliferative and inflammatory disorders
11/13/2008US20080279850 Tetraspanin specific immunoglobulin for use in the treatment and prevention of non-burkitt's malignancy
11/13/2008US20080279849 B lymphocyte chemoattractant (CXCL13) specific immunoglobulin for use in treatment and prevention of autoimmune encephalomyelitis
11/13/2008US20080279848 Using mixture comprising cluster of differentiation-4 (CD4) specific immunoglobulin and/or cyclophosphamide, mycophenolate mofetil and/or CTLA4-Ig to treat and prevent autoimmune, skin, inflammatory and respiratory system disorders
11/13/2008US20080279847 Tumor-associated glycoprotein-72 specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders
11/13/2008US20080279846 lipoprotein-associated phospholipase A2 (Lp-PLA2)
11/13/2008US20080279845 Combination therapy with a compound acting as a platelet adp receptor inhibitor
11/13/2008US20080279844 Methods for Treating Cancer Targeting Transglutaminase
11/13/2008US20080279822 Crystalline Polymorphs of a CXC-Chemokine Receptor Ligand
11/13/2008US20080279820 Compositions and Methods for Treating Burns
11/13/2008US20080279819 Therapeutic mixture comprising uncompetitive n-methylaspartic acid receptor antagonist, glatiramer acetate and monoclonal antibody for use in treatment of multiple sclerosis
11/13/2008US20080279816 A polypeptide covalently attached with a polyethylene glycol propionaldehyde group having anti-hepatitis C activity; multiple sclerosis
11/13/2008US20080279815 Method for developing testing, and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates
11/13/2008US20080279813 Using interferon and interleukin receptor expression profiles as evaluative tools in diagnosis of cancer, autoimmune, allergic, transplant rejection and infectious disorders
11/13/2008US20080279812 Disease Prevention and Vaccination Prior to Thymic Reactivation
11/13/2008US20080279785 Novel synthetic agonists of toll-like receptors containing CG dinucleotide modifications
11/13/2008US20080279767 Cancerous disease modifying antibodies
11/13/2008CA2723320A1 Il-12 immunotherapy for cancer
11/13/2008CA2687395A1 Complement factor h-derived short consensus repeat-antibody constructs
11/13/2008CA2686398A1 Two-component genome flavivirus and uses thereof
11/13/2008CA2685954A1 Antibodies binding to an intracellular prl-1 or prl-3 polypeptide
11/13/2008CA2685896A1 Method for the diagnosis of tuberculosis by detecting an immune response to ompatb
11/13/2008CA2685805A1 Klebsiella antigens
11/13/2008CA2685506A1 Vaccine
11/13/2008CA2685465A1 Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune disease
11/13/2008CA2685372A1 Method for stabilizing a protein
11/13/2008CA2684906A1 Cancerous disease modifying antibodies
11/13/2008CA2666179A1 Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease
11/12/2008EP1990413A1 Screening method for candidate drugs
11/12/2008EP1990410A1 IMMUNOTHERAPY BY USING CELL CAPABLE OF CO-EXPRESSING TARGET ANTIGEN AND CD1d AND PULSED WITH CD1d LIGAND
11/12/2008EP1990060A1 Remedy for disease associated with choroidal angiogenesis
11/12/2008EP1990058A1 Aglyco products and their use for inhibiting infection by influenza virus, and useof hexosamine precursor in schizophrenia treatment
11/12/2008EP1990057A1 Beta-secretase substrates and uses thereof
11/12/2008EP1989551A2 Method of detecting or diagnosing of a neurodegenerative disease or condition
11/12/2008EP1989330A2 Alpha-synuclein kinase
11/12/2008EP1989316A2 Method for the production of recombinant virus, dna constructs, recombinant virus and vaccine compositions
11/12/2008EP1989308A1 Methods and compositions to treat and detect misfolded-sod1 mediated diseases
11/12/2008EP1989233A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
11/12/2008EP1989232A1 Cytotoxicity mediation of cells evidencing surface expression of cd59
11/12/2008EP1989231A2 Combinatorial therapy involving alpha5beta1 antagonists
11/12/2008EP1989230A2 Anti-fgf19 antibodies and methods using same
11/12/2008EP1989224A2 Immunogenic peptides and methods of use
11/12/2008EP1989216A2 Diagnosis and treatment of prostate cancer
11/12/2008EP1989144A2 An extracorporeal cell-based therapeutic device and delivery system
11/12/2008EP1988927A2 Engineered antibody-stress protein fusions
11/12/2008EP1988923A1 Methods for treating unwanted weight loss or eating disorders by administering a trkb agonist
11/12/2008EP1988922A2 Protein formulations
11/12/2008EP1988921A2 Methods of treating inflammatory and autoimmune diseases with natalizumab
11/12/2008EP1988920A1 Methods for treating obesity by administering a trkb antagonist
11/12/2008EP1988919A2 Yeast-based vaccine for inducing an immune response
11/12/2008EP1988918A2 Adjuvant and vaccine compositions
11/12/2008EP1988882A2 Prolongation of survival of an allograft by inhibiting complement activity
11/12/2008EP1988768A2 Gene disruptions, compositions and methods relating thereto
11/12/2008EP1950222A9 Method for detecting antibodies in body fluids via an immune reaction with glycoprotein 2 (GP2) from zymogen granula of the pancreas for a differential diagnosis of inflammatory bowel diseases and chronic pancreatitis
11/12/2008EP1561759B1 Cell death-inducing agent
11/12/2008EP1523582B1 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same
11/12/2008EP1478738B1 Anti-ccr5 antibody
11/12/2008EP1444349B1 Polypeptides of moraxella (branhamella) catarrhalis
11/12/2008EP1432729B1 Peyers's patch and/or m-cell targeting ligands
11/12/2008EP1414994B9 Vaccinia virus for diagnosis and therapy of tumors
11/12/2008EP1404305B1 Pharmacological preparation made from a nanoparticulate mesomorphous polyelectrolyte lipid complex and at least one active ingredient
11/12/2008EP1395275B1 Beta-secretase substrate and uses thereof
11/12/2008EP1392831B1 Moraxella(branhamella) catarrhalis antigens
11/12/2008EP1259615B1 Antibodies against eotaxin and their use
11/12/2008EP1232184B1 Antibody against the human toll-like receptor-2 (tlr2) and uses thereof
11/12/2008EP1204421B1 Stress protein-peptide complexes as vaccines against intra-cellular pathogens
11/12/2008EP1064551B1 Development of human monoclonal antibodies and uses thereof
11/12/2008EP0950103B1 Survivin, a protein that inhibits cellular apoptosis, and its modulation
11/12/2008EP0792359B1 Transcription factor e2f-4
11/12/2008EP0701569B1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
11/12/2008CN101305021A Compositions and methods for diagnosing and treating an inflammation
11/12/2008CN101304765A Conjugation of streptococcal capsular saccharides
11/12/2008CN101304761A Treatment with an oncolytic virus and an immunostimulant for in vivo enhancement of immune system recognition of neoplasms
11/12/2008CN101304760A Dengue virus capsid protein which induces a protective response and pharmaceutical composition
11/12/2008CN101304759A Vaccines using pattern recognition receptor-ligand:lipid complexes
11/12/2008CN101302515A Human antibodies that bind human TNF(alpha)
11/12/2008CN101302500A Vaccine
11/12/2008CN100432105C Humanized antibody (H14.18) of the mouse 14.18 antibody binding to GD2 and its fusion with 1L-2
11/12/2008CN100432103C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells.
11/12/2008CN100432098C Antigen epitope I of B cell of chicken IBDV VP3 protein
11/12/2008CN100432096C Transfer factor specific for SARS virus and method for preparing same
11/12/2008CN100431612C Hepatitis B nucleic acid vaccine, its preparation method and application
11/11/2008US7449616 Monoclonal antibody for use in prevention and treatment of osteoarthritic and surgical pain; immunotherapy
11/11/2008US7449566 Polynucleotide encoding novel HCV non-structural polypeptide
11/11/2008US7449557 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
11/11/2008US7449556 genetic engineered antibody fragment having preferential binding for RNA virus epitopes, with variable light or heavy chain domains;immunology; veternary medicine
11/11/2008US7449555 Antibodies of angiogenesis inhibiting domains CD148
11/11/2008US7449551 PRO211 polypeptides
11/11/2008US7449548 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
11/11/2008US7449450 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
11/11/2008US7449324 Determining in a sample of an animal the presence of a viral component by reacting the sample with a nucleic acid or an antibody reactive with component of an avian pneumovirus, and crossreactive with a component of MPV (metapneumovirus)
11/11/2008US7449323 immunizing a cat with vaccine against a hemorrhagic feline calicivirus (hFCV); veterinary medicine
11/11/2008US7449321 Controlling a flavivirus entry into a cell by administering to the cell an agent functionally interfering with a flavivirus receptor protein, the flavivirus receptor protein being an integrin
11/11/2008US7449315 Bifunctional energy-reversible acyl-compositions
11/11/2008US7449310 For conferring protective immunity against F. necrophorum
1 ... 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 ... 1823